Molecular target validation and profiling of a novel class of anti-triple-negative breast cancer (TNBC) small-molecule Wnt pathway inhibitors. - Texts

Home
Main Navigation
Content
Search
Help

Font Standard Bold
Login

Research unit

INNOSUISSE

Project number

29722.1 IP-LS

Project title

Molecular target validation and profiling of a novel class of anti-triple-negative breast cancer (TNBC) small-molecule Wnt pathway inhibitors.

Texts for this project

	German	French	Italian	English
Short description		-	-
Abstract		-	-	-

Inserted texts

Category	Text
Short description (German)	Molecular target validation and profiling of a novel class of anti-triple-negative breast cancer (TNBC) small-molecule Wnt pathway inhibitors.
Short description (English)	Molecular target validation and profiling of a novel class of anti-triple-negative breast cancer (TNBC) small-molecule Wnt pathway inhibitors.
Abstract (German)	This project aims to validate and provide necessary data on the molecular target(-s) of our novel anti-Wnt signaling scaffold demonstrating excellent anti-cancer properties and safety profile. These data are essential for their acceptance and further structure-driven development in pharma companies.